These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38192036)

  • 1. Therapeutic Drug Monitoring of Voriconazole in Patients with End-Stage Liver Disease.
    Wu Z; Jiang M; Yan M; Li G; Zeng Z; Zhang X; Li N; Jiang Y; Gong G; Zhang M
    Ther Drug Monit; 2024 Feb; 46(1):89-94. PubMed ID: 38192036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Influence of Proinflammatory Cytokines on Voriconazole Trough Concentration in Patients With Different Forms of Hematologic Disorders.
    Mafuru M; Wu S; He S; Lu X; Huang J; Jiang H
    J Clin Pharmacol; 2019 Oct; 59(10):1340-1350. PubMed ID: 30997931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of procalcitonin with voriconazole concentrations: a retrospective cohort study.
    Zhou JX; Xiong CL; Chang ZS; Yin YC; Su KP; Zhang JH; Wu JC; Sun B
    BMC Infect Dis; 2024 Sep; 24(1):952. PubMed ID: 39256640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability of voriconazole concentrations in patients with hematopoietic stem cell transplantation and hematological malignancies: influence of loading dose, procalcitonin, and pregnane X receptor polymorphisms.
    Zeng G; Wang L; Shi L; Li H; Zhu M; Luo J; Zhang Z
    Eur J Clin Pharmacol; 2020 Apr; 76(4):515-523. PubMed ID: 31932875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective, multicenter study of voriconazole trough concentrations and safety in patients with Child-Pugh class C cirrhosis.
    Wang T; Yan M; Tang D; Xue L; Zhang T; Dong Y; Zhu L; Wang X; Dong Y
    J Clin Pharm Ther; 2018 Dec; 43(6):849-854. PubMed ID: 29893015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Plasma Trough Concentration of Voriconazole and Voriconazole N-Oxide in Its Hepatotoxicity in Adult Patients.
    Cheng L; You X; Wang X; Yu M; Jia C
    Drug Des Devel Ther; 2024; 18():3617-3628. PubMed ID: 39156484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring and safety of voriconazole therapy in patients with Child-Pugh class B and C cirrhosis: A multicenter study.
    Wang T; Yan M; Tang D; Xue L; Zhang T; Dong Y; Zhu L; Wang X; Dong Y
    Int J Infect Dis; 2018 Jul; 72():49-54. PubMed ID: 29793038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections.
    Lamoureux F; Duflot T; Woillard JB; Metsu D; Pereira T; Compagnon P; Morisse-Pradier H; El Kholy M; Thiberville L; Stojanova J; Thuillez C
    Int J Antimicrob Agents; 2016 Feb; 47(2):124-31. PubMed ID: 26775563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a mathematical prediction model for voriconazole stable maintenance dose: a prospective study.
    Zhou L; Li M; Li H; Guo Z; Gao Y; Zhang H; Qin F; Sang Z; Xing Q; Cheng L; Cao W
    Front Cell Infect Microbiol; 2023; 13():1157944. PubMed ID: 37565064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients--an evidence-based approach.
    Karthaus M; Lehrnbecher T; Lipp HP; Kluge S; Buchheidt D
    Ann Hematol; 2015 Apr; 94(4):547-56. PubMed ID: 25697592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voriconazole plasma concentrations and dosing in paediatric patients below 24 months of age.
    Gastine SE; Rauwolf KK; Pieper S; Hempel G; Lehrnbecher T; Tragiannidis A; Groll AH
    Mycoses; 2023 Nov; 66(11):969-976. PubMed ID: 37553971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypokalemia and Hyponatremia in Adult Patients Receiving Voriconazole Therapeutic Drug Monitoring.
    Cheng L; Liu Z; Yu M; Lin L; Xiong L; Dai Q
    J Clin Pharmacol; 2024 Apr; 64(4):461-468. PubMed ID: 37910022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical Analysis of Voriconazole Concentrations in Cerebrospinal Fluid and Blood in Patients with Ryptococcal Meningitis].
    Xiao GR; Liu ZZ; Tang GM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):192-197. PubMed ID: 36647666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate correlation between systemic IL-6 responses and CRP with trough concentrations of voriconazole.
    Vreugdenhil B; van der Velden WJFM; Feuth T; Kox M; Pickkers P; van de Veerdonk FL; Blijlevens NMA; Brüggemann RJM
    Br J Clin Pharmacol; 2018 Sep; 84(9):1980-1988. PubMed ID: 29744898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Analysis of the Effect of Inflammation on Voriconazole Trough Concentrations.
    Encalada Ventura MA; van Wanrooy MJ; Span LF; Rodgers MG; van den Heuvel ER; Uges DR; van der Werf TS; Kosterink JG; Alffenaar JW
    Antimicrob Agents Chemother; 2016 May; 60(5):2727-31. PubMed ID: 26883707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voriconazole in Hematopoietic Stem Cell Transplantation and Cellular Therapies: Real-World Usage and Therapeutic Level Attainment at a Major Transplantation Center.
    Lindsay J; Krantz EM; Morris J; Sweet A; Tverdek F; Joshi A; Yeh R; Hill JA; Greenwood M; Chen SC; Kong DCM; Slavin M; Pergam SA; Liu C
    Transplant Cell Ther; 2022 Aug; 28(8):511.e1-511.e10. PubMed ID: 35623614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation Affects Liver Function and the Metabolism of Voriconazole to Voriconazole-N-Oxide in Adult and Elderly Patients.
    Liang Z; Yu M; Liu Z; Liu F; Jia C; Xiong L; Dai Q; Qin S; Cheng L; Sun F
    Front Pharmacol; 2022; 13():835871. PubMed ID: 35462904
    [No Abstract]   [Full Text] [Related]  

  • 18. Using Child-Pugh Class to Optimize Voriconazole Dosage Regimens and Improve Safety in Patients with Liver Cirrhosis: Insights from a Population Pharmacokinetic Model-based Analysis.
    Wang T; Yan M; Tang D; Dong Y; Zhu L; Du Q; Sun D; Xing J; Dong Y
    Pharmacotherapy; 2021 Feb; 41(2):172-183. PubMed ID: 33064889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug interaction of voriconazole-cyclosporine in children undergoing hematopoietic stem cell transplantation (2013-2014)].
    Valenzuela R; Torres JP; Salas C; Gajardo I; Palma J; Catalán P; Santolaya ME; Morales J
    Rev Chilena Infectol; 2017 Feb; 34(1):14-18. PubMed ID: 28394976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Voriconazole Trough Plasma Concentration with Efficacy and Incidence of Hepatotoxicity in Iranian Patients with Hematological Malignancies.
    Taghvaye-Masoumi H; Hadjibabaie M; Ghadimi M; Zarif-Yeganeh M; Vaezi M; Ghavamzadeh A
    Iran J Pharm Res; 2021; 20(1):62-71. PubMed ID: 34400941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.